0001209191-21-023758.txt : 20210331
0001209191-21-023758.hdr.sgml : 20210331
20210331160207
ACCESSION NUMBER: 0001209191-21-023758
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200706
FILED AS OF DATE: 20210331
DATE AS OF CHANGE: 20210331
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GILMAN STEVEN C
CENTRAL INDEX KEY: 0001379970
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36365
FILM NUMBER: 21793172
MAIL ADDRESS:
STREET 1: 110 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SCYNEXIS INC
CENTRAL INDEX KEY: 0001178253
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562181648
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 EVERTRUST PLAZA
STREET 2: 13TH FLOOR
CITY: JERSEY CITY
STATE: NJ
ZIP: 07302-6548
BUSINESS PHONE: 201-884-5485
MAIL ADDRESS:
STREET 1: 1 EVERTRUST PLAZA
STREET 2: 13TH FLOOR
CITY: JERSEY CITY
STATE: NJ
ZIP: 07302-6548
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2020-07-06
2020-07-06
0
0001178253
SCYNEXIS INC
SCYX
0001379970
GILMAN STEVEN C
1 EVERTRUST PLAZA, 13TH FLOOR
JERSEY CITY
NJ
07302-6548
1
0
0
0
Stock Option (Right to Buy)
0.73
2020-07-06
4
A
0
55000
0.00
A
2030-07-05
Common Stock
55000
55000
D
One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant, provided that the non-employee director is providing continuous services on the applicable vesting date.
This Form 4/A is being filed only to correct the number of shares subject to the stock option acquired by the Reporting Person, which was originally reported to have been 45,000 on 7/6/2020 but was 55,000. Subsequent to the date of grant, the Issuer effected a 1-for-10 reverse stock split and, accordingly, this stock option has become an option to acquire 5,500 shares with an exercise price of $7.30 per share.
/s/ Robert F. Joyce Jr., by Power of Attorney
2021-03-31